>
Nanexa AB logo

NANEXA UR - Nanexa AB Share Price

SEK0.1 0.0  0.0%

Last Trade - 21/02/20

Sector
Healthcare
Size
Micro Cap
Market Cap £16.7m
Enterprise Value £15.8m
Revenue £201k
Position in Universe th / 1832
Bullish
Bearish
Unlock NANEXA UR Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.32 1.71 2.37 8.50 8.50 +172.4%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, NanexaAB revenues increased 38% to SEK2.4M. Net loss increased68% to SEK21.7M. Revenues reflect an increase in demand forthe Company's products and services due to favorable marketconditions. Higher net loss reflects Other External Expenseincrease from SEK10.3M to SEK24.4M (expense), Labor &Related Expenses in SGA increase of 63% to SEK12.6M(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

NANEXA UR Revenue Unlock NANEXA UR Revenue

Net Income

NANEXA UR Net Income Unlock NANEXA UR Revenue

Normalised EPS

NANEXA UR Normalised EPS Unlock NANEXA UR Revenue

PE Ratio Range

NANEXA UR PE Ratio Range Unlock NANEXA UR Revenue

Dividend Yield Range

NANEXA UR Dividend Yield Range Unlock NANEXA UR Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
NANEXA UR EPS Forecasts Unlock NANEXA UR Revenue
Profile Summary

Nanexa AB is a Sweden-based company engaged in the drug delivery systems industry. The Company specializes in the nanotechnology and research and development in life science. Its products portfolio is comprised of PharmaShell, a drug delivery system that allows for targeting and dosing of drugs; antifungal coating, a system that protects medical products from the in-growth of fungi; and low-friction coating for peripheral venous catheters.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Public Since June 17, 2015
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange AktieTorget Stock Exchange (Dual Listing)
Shares in Issue 21,223,854
Free Float (0.0%)
Eligible for
ISAs
SIPPs
NANEXA UR Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for NANEXA UR
Upcoming Events for NANEXA UR
Frequently Asked Questions for Nanexa AB
What is the Nanexa AB share price?

As of 21/02/20, shares in Nanexa AB are trading at SEK0.1, giving the company a market capitalisation of £16.7m. This share price information is delayed by 15 minutes.

How has the Nanexa AB share price performed this year?

Shares in Nanexa AB are currently trading at SEK0.1 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Nanexa AB price has moved by % over the past year.

What are the analyst and broker recommendations for Nanexa AB?

There are no analysts currently covering Nanexa AB.

When will Nanexa AB next release its financial results?

Nanexa AB is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Nanexa AB dividend yield?

Nanexa AB does not currently pay a dividend.

Does Nanexa AB pay a dividend?

Nanexa AB does not currently pay a dividend.

When does Nanexa AB next pay dividends?

Nanexa AB does not currently pay a dividend.

How do I buy Nanexa AB shares?

To buy shares in Nanexa AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Nanexa AB?

Shares in Nanexa AB are currently trading at SEK0.1, giving the company a market capitalisation of £16.7m.

Where are Nanexa AB shares listed? Where are Nanexa AB shares listed?

Here are the trading details for Nanexa AB:

Country of listing: Sweden
Exchange: AKT
Ticker Symbol: NANEXA UR
What kind of share is Nanexa AB?

We were not able to load our ranking data for Nanexa AB

Is there a Nanexa AB share price forecast 2021?

We were not able to load any forecast data for Nanexa AB.

How can I tell whether the Nanexa AB share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nanexa AB. Over the past six months, the relative strength of its shares against the market has been %. At the current price of SEK0.1, shares in Nanexa AB are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Nanexa AB PE Ratio?

We were not able to find PE ratio data for Nanexa AB.

Who are the key directors of Nanexa AB?

We were unable to find the directors for Nanexa AB.

Who are the major shareholders of Nanexa AB?

Here are the top five shareholders of Nanexa AB based on the size of their shareholding:

Similar to NANEXA UR
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.